Explore

Doctors Alarmed by New Cases of Hib Amidst Vaccine Hesitancy

Doctors Alarmed by New Cases of Hib Amidst Vaccine Hesitancy

Recent reports indicate a resurgence of Haemophilus influenzae type B (Hib), a potentially deadly bacterial infection, in the United States. Historically, Hib affected 20,000 children annually, causing severe illnesses such as pneumonia and meningitis. The introduction of the Hib vaccine over three decades ago drastically reduced cases by more than 99%, with current annual cases numbering fewer than 50. However, recent hospitalizations of unvaccinated children in Florida and Tennessee have raised concerns among health experts about a potential comeback of the disease. The Centers for Disease Control and Prevention (CDC) has not reported an increase in preventable Hib infections, but experts warn that declining vaccination rates could lead to a resurgence.

Doctors Alarmed by New Cases of Deadly Hib Disease in Unvaccinated Children

Doctors Alarmed by New Cases of Deadly Hib Disease in Unvaccinated Children

Recent hospitalizations of children for Haemophilus influenzae type B (Hib) have raised concerns among doctors about the potential resurgence of this once-feared disease. Hib, which spreads through respiratory droplets, can cause severe infections like pneumonia and meningitis, leading to permanent disabilities or death. The Hib vaccine, introduced over three decades ago, drastically reduced cases, but declining vaccination rates are causing worry. Recent cases in Florida and Tennessee have sparked concern, with unvaccinated children suffering severe outcomes.

CDC Reports Detection of New Covid Variant BA.3.2 Across U.S., Experts Advise Caution

CDC Reports Detection of New Covid Variant BA.3.2 Across U.S., Experts Advise Caution

The Centers for Disease Control and Prevention (CDC) has identified a new Covid-19 variant, BA.3.2, in 29 U.S. states and Puerto Rico. This variant, a subvariant of Omicron, features numerous spike protein mutations. Despite its emergence, experts, including Dr. Jake Scott from Stanford, emphasize that there is no current evidence suggesting BA.3.2 is more severe than other variants. The World Health Organization (WHO) has classified it as a 'variant under monitoring' but has not elevated it to a higher risk category. Current vaccines continue to provide protection against severe illness, and public health measures such as masking and improved ventilation are recommended in high-risk settings. The variant has not shown a significant growth advantage over other variants, and there is no indication of increased severity or hospitalizations associated with it.

CDC Reports on Cleanliness of Cruise Lines Amid Norovirus Outbreaks

CDC Reports on Cleanliness of Cruise Lines Amid Norovirus Outbreaks

The Centers for Disease Control and Prevention (CDC) has released data evaluating the cleanliness of cruise lines, highlighting both the cleanest and those with the highest number of norovirus outbreaks. Viking Ocean, Viking Expedition, and Crystal Cruises were identified as the cleanest, each scoring an average of 99 out of 100. Despite high cleanliness scores, the cruise industry saw a 28% increase in illness outbreaks in 2025 compared to the previous year, with norovirus responsible for 74% of these incidents. The CDC's inspections, which rank ships on a 100-point scale, revealed that while many cruise lines maintain high hygiene standards, the close quarters of ships make them susceptible to rapid virus spread.

New Covid Variant BA.3.2 Detected in U.S., Experts Advise Caution Over Alarm

New Covid Variant BA.3.2 Detected in U.S., Experts Advise Caution Over Alarm

The Centers for Disease Control and Prevention (CDC) has reported the detection of a new Covid-19 variant, BA.3.2, across 29 U.S. states and Puerto Rico. This variant, a subvariant of Omicron, features numerous mutations in its spike protein. Despite its presence, experts, including Dr. Jake Scott from Stanford, emphasize that there is no current evidence suggesting BA.3.2 is more severe than other variants. The World Health Organization (WHO) has classified it as a 'variant under monitoring' but has not elevated its risk status. Current vaccines continue to provide protection against severe disease, and the variant has not shown a significant growth advantage over other variants. In Europe, BA.3.2 has become more prevalent in some areas without leading to worse clinical outcomes.

High-Dose Flu Vaccine Linked to Lower Alzheimer's Risk in Older Adults

High-Dose Flu Vaccine Linked to Lower Alzheimer's Risk in Older Adults

A recent study published in Neurology has found that receiving a high-dose flu vaccine is associated with a significantly lower risk of developing Alzheimer's disease in adults aged 65 and older. Conducted by researchers at the McGovern Medical School at UTHealth in Houston, the study analyzed health data from approximately 165,000 older adults who received either a high-dose or standard-dose influenza vaccine. The findings revealed that the high-dose flu vaccine reduced the risk of Alzheimer's by nearly 55% over a two-year period. This study builds on previous research by the same team, which found that the standard-dose vaccine was linked to a 40% reduced risk of Alzheimer's over four years. The high-dose vaccine contains four times the antigen of standard-dose vaccines, which is believed to enhance immune response and reduce inflammation, a factor thought to contribute to Alzheimer's development.

CDC Temporarily Halts Testing for Infectious Diseases Amid Workforce Reductions

CDC Temporarily Halts Testing for Infectious Diseases Amid Workforce Reductions

The Centers for Disease Control and Prevention (CDC) has temporarily suspended testing for several infectious diseases, including rabies and human herpesvirus, due to significant staffing shortages. This decision comes after a period of major workforce reductions at the CDC, with staffing levels dropping by 20% to 25%. The agency has been reviewing its testing programs since 2024 as part of a broader internal evaluation. The pause affects over two dozen types of testing, including those for common infections and less common organisms.

CDC Temporarily Halts Testing for Rabies, Monkeypox, and Other Diseases Amid Staffing Shortages

CDC Temporarily Halts Testing for Rabies, Monkeypox, and Other Diseases Amid Staffing Shortages

The Centers for Disease Control and Prevention (CDC) has announced a temporary pause in its diagnostic testing for several infectious diseases, including rabies, monkeypox, Epstein-Barr virus, and varicella zoster virus. This decision comes as the agency faces significant staffing shortages, with a reported reduction of 20% to 25% in its workforce over the past year. The CDC's laboratory operations have been under review since 2024, following criticisms during the COVID-19 pandemic. The agency has stated that the pause is part of a routine review to ensure high-quality laboratory testing. Despite the halt, the CDC is committed to supporting state and local partners in accessing necessary public health testing.

CDC Temporarily Halts Testing for Rabies and Monkeypox Amid Staffing Shortages

CDC Temporarily Halts Testing for Rabies and Monkeypox Amid Staffing Shortages

The Centers for Disease Control and Prevention (CDC) has temporarily paused its diagnostic testing for rabies, monkeypox, and other infectious diseases due to significant staffing shortages. This decision follows a period of major workforce reductions at the CDC, with estimates indicating a 20% to 25% drop in total staffing. The CDC's laboratory operations, which were criticized during the COVID-19 pandemic, have been under review since 2024. The agency has listed over two dozen types of testing that are currently unavailable. Despite the pause, the CDC is working to support state and local partners in accessing necessary public health testing.

Scientists Uncover How Body Contains Latent Tuberculosis, Paving Way for New Vaccine

Scientists Uncover How Body Contains Latent Tuberculosis, Paving Way for New Vaccine

Researchers at James Cook University have made significant strides in understanding how the body contains latent tuberculosis (TB) using advanced spatial transcriptomics. This technique allows scientists to map interactions between immune cells and bacteria within tissues, revealing that latent Mycobacterium tuberculosis often resides in lymphatic organs rather than the lungs. The study, published in Nature Communications, highlights the role of CD8+ T cells in containing the infection, providing insights that support early testing of new vaccine candidates to prevent TB reactivation. This research is crucial as latent TB affects around 2 billion people globally, with a risk of reactivation in 5-10% of cases.

ARPA-H Launches $144 Million STOMP Program to Combat Microplastics in Human Health

ARPA-H Launches $144 Million STOMP Program to Combat Microplastics in Human Health

The Advanced Research Projects Agency for Health (ARPA-H) has initiated a $144 million program named STOMP (Systematic Targeting Of MicroPlastics) to address the pervasive issue of microplastics in human health. The program aims to develop fast, affordable, and widely accessible tools to protect vulnerable populations, such as pregnant women and children, from long-term diseases caused by microplastics. The first phase focuses on creating standardized clinical tests to measure microplastic burden in humans, with the Centers for Disease Control and Prevention (CDC) acting as an independent validator. This phase will also establish a risk stratification mechanism to prioritize plastics based on their biological harm. The second phase will involve designing interventions to safely remove microplastics from human organs using pharmaceutical biology and bioremediation science.

CDC Reports New Cicada COVID Variant BA.3.2 Detected in U.S. Wastewater

CDC Reports New Cicada COVID Variant BA.3.2 Detected in U.S. Wastewater

A new COVID-19 variant, BA.3.2, nicknamed 'Cicada,' has been identified in the United States, according to a recent report by the Centers for Disease Control and Prevention (CDC). This variant has been detected in 23 countries and in up to 132 wastewater samples from 25 U.S. states. The Cicada variant is a descendant of the Omicron strain and has undergone significant mutations, particularly in its spike protein, which may allow it to partially evade immunity from previous infections or vaccinations. Despite these mutations, the variant is not currently the dominant strain in the U.S. and its symptoms align with those of other COVID-19 strains, including fever, cough, and fatigue.